BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2962338)

  • 1. Blood ammonia levels and hepatic encephalopathy induced by CCl4 in rats.
    Yamamoto H; Sugihara N
    Toxicol Appl Pharmacol; 1987 Dec; 91(3):461-8. PubMed ID: 2962338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic ATP content and hyperammonemia induced by CCl4 in rats.
    Yamamoto HA; Sugihara N
    Toxicology; 1988 Sep; 51(1):111-7. PubMed ID: 3413798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain phenylalanine and tyrosine levels and hepatic encephalopathy induced by CCl4 in rats.
    Yamamoto H
    Toxicology; 1990 Apr; 61(3):241-7. PubMed ID: 2330597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered hepatic energy status in chlordecone (Kepone)-potentiated CCl4 hepatotoxicity.
    Kodavanti PR; Kodavanti UP; Mehendale HM
    Biochem Pharmacol; 1990 Aug; 40(4):859-66. PubMed ID: 1696822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect of HD-03 in CCl4-induced hepatic encephalopathy in rats.
    Mitra SK; Venkataranganna MV; Gopumadhavan S; Anturlikar SD; Seshadri SJ; Venkatesha Udupa U
    Phytother Res; 2001 Sep; 15(6):493-6. PubMed ID: 11536377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship of CPS-I, OCT and hepatic encephalopathy].
    He Y; Song HL; Li GX; Xu J; Gao BX; Yu T; Tang SQ
    Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):699-702. PubMed ID: 20943084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urea synthesis in the African lungfish Protopterus dolloi--hepatic carbamoyl phosphate synthetase III and glutamine synthetase are upregulated by 6 days of aerial exposure.
    Chew SF; Ong TF; Ho L; Tam WL; Loong AM; Hiong KC; Wong WP; Ip YK
    J Exp Biol; 2003 Oct; 206(Pt 20):3615-24. PubMed ID: 12966053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taurine treatment preserves brain and liver mitochondrial function in a rat model of fulminant hepatic failure and hyperammonemia.
    Jamshidzadeh A; Heidari R; Abasvali M; Zarei M; Ommati MM; Abdoli N; Khodaei F; Yeganeh Y; Jafari F; Zarei A; Latifpour Z; Mardani E; Azarpira N; Asadi B; Najibi A
    Biomed Pharmacother; 2017 Feb; 86():514-520. PubMed ID: 28024286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hyperammonemia with carbamylglutamate in rats.
    Grau E; Felipo V; Miñana MD; Grisolía S
    Hepatology; 1992 Mar; 15(3):446-8. PubMed ID: 1544625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of calcium homeostasis leads to progressive phase of chlordecone-potentiated carbon tetrachloride hepatotoxicity.
    Kodavanti PR; Rao VC; Mehendale HM
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):77-87. PubMed ID: 7690997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cirrhotic rats with L-ornithine-L-aspartate enhances urea synthesis and lowers serum ammonia levels.
    Gebhardt R; Beckers G; Gaunitz F; Haupt W; Jonitza D; Klein S; Scheja L
    J Pharmacol Exp Ther; 1997 Oct; 283(1):1-6. PubMed ID: 9336301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperammonemia and hepatic encephalopathy in cirrhotics receiving spironolactone (author's transl)].
    Imler M; Schlienger JL
    Nouv Presse Med; 1977 Nov; 6(37):3407-10. PubMed ID: 600713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional changes of brain mitochondria during experimental hepatic encephalopathy.
    Díaz-Muñoz M; Tapia R
    Biochem Pharmacol; 1989 Nov; 38(21):3835-41. PubMed ID: 2532014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection from chlordecone-amplified carbon tetrachloride toxicity by cyanidanol: biochemical and histological studies.
    Soni MG; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):46-57. PubMed ID: 1706539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-chain fatty acids suppress the induction of urea cycle enzyme genes by glucocorticoid action.
    Tomomura M; Tomomura A; Dewan MA; Saheki T
    FEBS Lett; 1996 Dec; 399(3):310-2. PubMed ID: 8985169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of carbamoyl phosphate synthetase-I by dietary dehydroepiandrosterone.
    Marrero M; Prough RA; Putnam RS; Bennett M; Milewich L
    J Steroid Biochem Mol Biol; 1991 May; 38(5):599-609. PubMed ID: 1828177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medium-chain triglycerides supplement therapy with a low-carbohydrate formula can supply energy and enhance ammonia detoxification in the hepatocytes of patients with adult-onset type II citrullinemia.
    Hayasaka K; Numakura C; Yamakawa M; Mitsui T; Watanabe H; Haga H; Yazaki M; Ohira H; Ochiai Y; Tahara T; Nakahara T; Yamashiki N; Nakayama T; Kon T; Mitsubuchi H; Yoshida H
    J Inherit Metab Dis; 2018 Sep; 41(5):777-784. PubMed ID: 29651749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological findings in livers of patients with urea cycle disorders.
    Yaplito-Lee J; Chow CW; Boneh A
    Mol Genet Metab; 2013 Mar; 108(3):161-5. PubMed ID: 23403242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of carbamyl phosphate synthetase-I and glutamine synthetase by hepatotoxic doses of acetaminophen in mice.
    Gupta S; Rogers LK; Taylor SK; Smith CV
    Toxicol Appl Pharmacol; 1997 Oct; 146(2):317-27. PubMed ID: 9344900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ammonia: key factor in the pathogenesis of hepatic encephalopathy.
    Butterworth RF; Giguère JF; Michaud J; Lavoie J; Layrargues GP
    Neurochem Pathol; 1987; 6(1-2):1-12. PubMed ID: 3306479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.